Browse Category

Alibaba News 13 January 2026 - 2 February 2026

Alibaba stock slips premarket after $431 million Qwen AI Lunar New Year blitz

Alibaba stock slips premarket after $431 million Qwen AI Lunar New Year blitz

Alibaba shares fell 0.8% to $168.17 in premarket trading after the company announced a 3 billion yuan ($431 million) investment to boost its Qwen AI app ahead of Lunar New Year. The campaign launches Feb. 6, with incentives distributed via digital red envelopes. Rival DeepSeek is expected to update its AI model mid-month. Alibaba’s next earnings report is scheduled for Feb. 19.
Alibaba stock slips into Monday: China PMI shock and AI chip access are the next tests

Alibaba stock slips into Monday: China PMI shock and AI chip access are the next tests

Alibaba’s U.S.-listed shares fell 2.7% to $169.56 Friday, with trading volume near 10.8 million. The drop followed weaker-than-expected Chinese manufacturing and services data, which renewed concerns about domestic demand. The Nasdaq lost 0.94% and the S&P 500 slipped 0.43%. Investors are watching for China’s upcoming economic data and Alibaba’s Feb. 19 earnings.
Hang Seng slips at open as Alibaba, Tencent slide — yet Hong Kong stocks eye best month in four

Hang Seng slips at open as Alibaba, Tencent slide — yet Hong Kong stocks eye best month in four

The Hang Seng Index fell 1.5% to 27,545 on Friday, ending a seven-session rally as traders took profits after a multi-year high. Alibaba dropped 1.9% and Tencent lost 1.1%, while materials stocks led declines. Investors await China’s official factory PMI on Saturday, with forecasts pointing to little change from December. Property shares rose this month on reports of eased borrowing limits for developers.
Alibaba stock price slips after AI-chip headlines; BABA traders turn to Fed week

Alibaba stock price slips after AI-chip headlines; BABA traders turn to Fed week

Alibaba’s U.S.-listed shares fell 2.2% to $173.23 Friday, while its Hong Kong stock closed up 2.25%. Traders reacted to reports that Chinese tech firms can order Nvidia’s H200 AI chips and to Alibaba Cloud’s new partner incentives. Bloomberg reported Alibaba plans to take its AI chip unit public. Investors await the U.S. Fed’s rate decision on Jan. 28.
Alibaba stock slips despite Nvidia H200 headline as traders size up China approval risk

Alibaba stock slips despite Nvidia H200 headline as traders size up China approval risk

Alibaba’s U.S.-listed shares fell 2.2% to $173.23 Friday after reports that Chinese regulators gave “in-principle” approval for tech firms to prepare Nvidia H200 AI chip orders. Uncertainty remains over official policy, with no formal quota set and the H200 still barred at customs. Trading volume reached 13.1 million shares. Investors await guidance from regulators or the company.
Alibaba stock price: BABA faces a holiday pause as China margin curbs and Nvidia H200 snag raise new questions

Alibaba stock price: BABA faces a holiday pause as China margin curbs and Nvidia H200 snag raise new questions

Alibaba’s U.S.-listed shares fell 3.24% to $165.40 Friday as Beijing moved to tighten margin rules and fresh doubts emerged over AI chip imports. Trading volume reached about 18.3 million shares. U.S. markets will remain closed Monday for Martin Luther King, Jr. Day, with trading resuming Jan. 20. Hong Kong-listed Alibaba shares closed up 0.97% at HK$166.20.
Alibaba stock falls after 111% surge as BABA valuation calls clash

Alibaba stock falls after 111% surge as BABA valuation calls clash

Alibaba’s U.S.-listed shares fell 3.24% Friday to $165.40, with 18.6 million shares traded. The stock sits about 14.5% below its 52-week high and has a market cap near $397.2 billion. Analyst price targets vary widely, with estimates ranging from $83.38 to $281.17 per share. Heavy spending on subsidies for quick commerce has pressured earnings despite accelerating cloud revenue growth.
18 January 2026
Alibaba stock price slips 3% into weekend as Qwen AI rollout meets China data week

Alibaba stock price slips 3% into weekend as Qwen AI rollout meets China data week

Alibaba shares fell 3.2% to $165.40 Friday, ending a short rally before the U.S. market holiday. The company upgraded its Qwen AI app this week, adding food delivery and travel booking features now in public testing across China. China’s GDP and activity data will be released Monday, with markets watching for signs of slowing growth.
Trip.com’s antitrust shock hits Hong Kong stocks as Hang Seng slips; Alibaba’s Qwen upgrade draws focus

Trip.com’s antitrust shock hits Hong Kong stocks as Hang Seng slips; Alibaba’s Qwen upgrade draws focus

Hong Kong’s Hang Seng Index closed down 0.5% at 26,866.29 Thursday, led by a sharp drop in Trip.com shares after news of a China antitrust probe. Trip.com fell as much as 21.7% before paring losses. Alibaba launched new Qwen app features for food delivery and travel booking. China raised minimum margin requirements for margin trading on major exchanges.
Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push

Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push

New York, January 13, 2026, 05:32 EST — Premarket Alibaba Group Holding Ltd’s U.S.-listed shares (BABA) grabbed attention ahead of Tuesday’s open after closing up 10.2% at $166.31 in the previous session. (Wall Street Journal) The rally counts because Alibaba is once again a spark for “China policy” trades — any sign of accelerated AI investment, eased competition, or stable pricing gets snapped up fast. This comes as U.S. markets gear up for new inflation figures, which often steer risk asset sentiment. The U.S. Consumer Price Index, a key inflation indicator, is set for release at 8:30 a.m. Eastern on
1 2 3

Stock Market Today

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026
New York, February 7, 2026, 05:48 EST — Market closed Pfizer Inc (PFE) shares ended Friday up 2.8% at $27.22, after trading between $26.52 and $27.37. About 50.7 million shares changed hands. (Yahoo Finance) The stock’s late-week lift comes with a key regulatory clock running: the FDA granted priority review for Pfizer’s supplemental filing to broaden use of its hemophilia drug Hympavzi, with a target decision deadline in the second quarter. Priority review shortens the agency’s standard review timeline by four months. “There is a significant medical need for younger patients with hemophilia and for those who have developed inhibitors,”
Go toTop